Drug company gives ofatumumab update
Drug company gives ofatumumab update
Biotech firm Genmab has announced an update on development plans for ofatumumab in autoimmune indications focusing on relapsing multiple sclerosis following the transfer of the rights to ofatumumab from GlaxoSmithKline (GSK) to Novartis at the end of 2015...Read more - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 1381 Views
-
Last post by frodo
-
- 0 Replies
- 1024 Views
-
Last post by frodo
-
- 0 Replies
- 2586 Views
-
Last post by NHE
-
- 0 Replies
- 1308 Views
-
Last post by frodo
-
- 0 Replies
- 1301 Views
-
Last post by frodo
-
- 0 Replies
- 1278 Views
-
Last post by frodo
-
- 0 Replies
- 1667 Views
-
Last post by NHE
-
- 0 Replies
- 489 Views
-
Last post by NHE
-
- 1 Replies
- 3135 Views
-
Last post by Tif